James Lacotte
Corneal and Contact Management · Madison, NJNPI 1215164991
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 83 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Alcon at 33.1% of the total.
Across 83 payments — averaging $18.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$514
- Biotissue Holdings Inc.$251
- Coopervision Inc.$167
- Johnson & Johnson Vision Care, Inc.$151
- Bausch & Lomb Americas Inc.$106
- Dompe US, Inc.$86
- plus $278 from 7 others
What the payments were for
- Food & beverage$1,553100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 25 | $514 |
| Biotissue Holdings Inc. | 15 | $251 |
| Coopervision Inc. | 4 | $167 |
| Johnson & Johnson Vision Care, Inc. | 10 | $151 |
| Bausch & Lomb Americas Inc. | 7 | $106 |
| Dompe US, Inc. | 5 | $86 |
| Tarsus Pharmaceuticals, Inc. | 5 | $85 |
| Oyster Point Pharma, Inc. | 3 | $53 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 3 | $42 |
| Novartis | 3 | $40 |
| Harrow Eye, LLC | 1 | $22 |
| Kala Pharmaceuticals, Inc. | 1 | $19 |
| Sun Pharmaceutical Industries Inc. | 1 | $17 |
How this compares
$1,553 in reported general payments places this provider in the 55th percentile of 45 corneal and contact management providers in New Jersey.
See all corneal and contact management providers in New Jersey →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Latanoprost | 95 | $732 |
| Timolol Maleate | 53 | $331 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 20 | $197 |
Paid to pharmacies, not to this prescriber.
Other corneal and contact management in Madison
- Bradford RippsLake Hopatcong$94K
- Vittorio MenaFairview$53K
- Kenneth DanielsLambertville$14K
- Thomas ConroyBloomfield$9K
- Alan SchlusselWest Orange$8K
- Danica YangCranford$7K
- Daniel IsaacCherry Hill$5K
- Amy SteinParamus$4K
- Paul DifioreMount Laurel$3K
- Jeffrey CaseFreehold$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.